Anti-MARCO treatment potently repolarised TAMs in an FcγRIIb-dependent manner and in combination with anti-CTLA4 immunotherapy showed enhanced anti-tumour effects in mouse models of melanoma and colon carcinoma [83]. This evidence concerns the gene CTLA4 and melanoma.